1 Min Read
Nov 7 (Reuters) - Pernix Therapeutics Holdings Inc
* Pernix Therapeutics reports third quarter 2017 financial results
* Q3 revenue fell 2 percent to $40.5 million Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.